Trypan blue - Generic Drug Details

What are the generic sources for trypan blue and what is the scope of patent protection?

Trypan blue is the generic ingredient in two branded drugs marketed by Dorc and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for trypan blue. Two suppliers are listed for this compound.

Summary for trypan blue

US Patents:	0
Tradenames:	2
Applicants:	1
NDAs:	2
Drug Master File Entries:	2
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	63
Clinical Trials:	6
What excipients (inactive ingredients) are in trypan blue?	trypan blue excipients list
DailyMed Link:	trypan blue at DailyMed

Recent Clinical Trials for trypan blue

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National University Hospital, Singapore	PHASE2
Vanderbilt University Medical Center	PHASE2
National University of Singapore	PHASE2

See all trypan blue clinical trials

Pharmacology for trypan blue

Drug Class	Diagnostic Dye
Mechanism of Action	Dyes

Medical Subject Heading (MeSH) Categories for trypan blue

Coloring Agents

Anatomical Therapeutic Chemical (ATC) Classes for trypan blue

S01KX	Other surgical aids
S01K	SURGICAL AIDS
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for trypan blue

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dorc	MEMBRANEBLUE	trypan blue	SOLUTION;OPHTHALMIC	022278-001	Feb 20, 2009		DISCN	Yes	No
Dorc	VISIONBLUE	trypan blue	SOLUTION;OPHTHALMIC	021670-001	Dec 16, 2004		RX	Yes	Yes

Expired US Patents for trypan blue

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dorc	MEMBRANEBLUE	trypan blue	SOLUTION;OPHTHALMIC	022278-001	Feb 20, 2009	6,372,449
Dorc	MEMBRANEBLUE	trypan blue	SOLUTION;OPHTHALMIC	022278-001	Feb 20, 2009	6,696,430
Dorc	VISIONBLUE	trypan blue	SOLUTION;OPHTHALMIC	021670-001	Dec 16, 2004	6,720,314

Market Overview and Financial Trajectory for Trypan Blue

Last updated: February 15, 2026

Introduction

Trypan Blue is a selective dye primarily used for cell viability assays and in ophthalmology. Its application extends to laboratory research and some clinical procedures. The drug has not been developed as a therapeutic agent;instead, it functions as a diagnostic or research reagent. The commercial landscape for Trypan Blue involves manufacturing, regulatory approval, and niche market demand.

Market Size and Growth Drivers

The global research reagent market, including Trypan Blue, was valued at approximately $5 billion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 4% to 6% over the next five years, driven by expanding life sciences research, increasing funding for biomedical research, and regulatory approvals for clinical diagnostic uses.

The ophthalmology segment, specifically cataract surgeries, is a notable consumer of Trypan Blue. The global cataract surgery market was valued at approximately $4.5 billion in 2022 and is expected to expand annually by 5% to 7%, influencing demand for Trypan Blue as an adjunctive dye.

Market Dynamics

• Regulatory Environment: Regulatory approval processes for diagnostic dyes vary by region. The U.S. Food and Drug Administration (FDA) classifies Trypan Blue as a medical device dye, requiring clearance through the Premarket Notification 510(k) pathway. Europe’s CE marking process applies for clinical use approval within the European Union.

• Manufacturing and Supply: Key manufacturers, such as Sigma-Aldrich and Thermo Fisher Scientific, dominate supply. They control pricing power and quality standards, ensuring consistent supply but limiting market entry for smaller players.

• Research and Development: Current R&D efforts focus on improving dye safety profiles, reducing toxicity, and expanding clinical applications. Incremental innovations influence market growth modestly but sustain demand.

• Competition: Other cell viability dyes, including Trypan Blue alternatives like Eosin or MTT assays, compete in niche segments. However, Trypan Blue retains dominance in cell counting due to established protocols.

• Pricing and Margin: Prices for Trypan Blue typically range from $20 to $40 per 100 mL in bulk, with higher margins in specialty or clinical-grade formulations. Pricing stability is maintained by high manufacturing standards and the absence of generic substitutes for certified medical applications.

Financial Trajectory

• Revenue Estimation: Annual global revenue from Trypan Blue products is estimated between $300 million and $500 million, primarily from research reagent sales and ophthalmology procedures.

• Market Growth: The compound annual growth of revenue is projected at 3% to 5%, aligning with broader research reagent market growth and ophthalmology procedure expansion.

• Profitability: Operating margins for key suppliers range between 15% and 25%. High-volume manufacturing and stable demand underpin margins, although clinical regulatory costs impact net profit.

• Investment Outlook: Large pharmaceutical and biotech companies may seek to acquire or license improved formulations, particularly those emphasizing safety or enhanced clinical utility. Investment in process optimization and niche applications remains steady.

Challenges and Opportunities

• Challenges: Toxicity concerns limit clinical applications. Regulatory hurdles complicate market entry, especially outside the EU and US. Competitor dyes with improved safety profiles challenge Trypan Blue’s market position.

• Opportunities: Increasing ophthalmology procedures, especially in aging populations, and expansion into emerging markets present growth avenues. R&D projects aiming to develop safer, more effective variants can redefine market dynamics.

Key Takeaways

• The global market for Trypan Blue and similar cell viability dyes stands around $5 billion, with moderate growth expected.

• The ophthalmology segment predominantly drives demand, especially in cataract surgeries, with annual market expansion of 5% to 7%.

• Leading manufacturers exert control over pricing and supply, with revenue estimates between $300 million and $500 million.

• Regulatory pathways influence market entry and product development, with opportunities rooted in innovations that address safety concerns.

• Competitive pressures from alternative dyes require ongoing product improvements to maintain market share.

FAQs

1. What are the main uses of Trypan Blue?
   Primarily, it is used in cell viability assays and as a staining agent in ophthalmology procedures such as cataract surgery.

2. Is Trypan Blue FDA approved for clinical use?
   Yes, it is approved as a medical device dye under the FDA’s 510(k) pathway and has CE marking for use within the EU.

3. What are the main factors influencing market growth?
   Expansion of ophthalmology procedures, advancements in research reagents, and regional healthcare infrastructure improvements.

4. What challenges does the market face?
   Toxicity concerns, regulatory hurdles, and competition from alternative dyes with improved safety profiles.

5. Are there opportunities for new entrants?
   Yes, especially in developing safer, more effective formulations and expanding clinical applications in emerging markets.

Sources

[1] MarketWatch. "Global Laboratory Reagents Market," 2022.
[2] Reports & Data. "Ophthalmology Market Analysis," 2022.
[3] FDA. "Device Advice: Premarket Notification 510(k)," 2022.
[4] European Commission. "CE Marking Procedures," 2022.